Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Intervalo de año de publicación
1.
Arq. bras. med. vet. zootec. (Online) ; 71(4): 1375-1386, jul.-ago. 2019. tab, graf
Artículo en Inglés | LILACS, VETINDEX | ID: biblio-1038600

RESUMEN

Reproductive efficacy of sows dictates the level of profitability of the production itself, and the moment of testing and selection of gilts for breeding (as the parents of a future generation), represents a very important moment. Given the fact that the selection of gilts for breeding is partly based on the weight-gain in the test, in this study we examined the influence of a daily weight-gain of gilts in the test of the manifestation of important reproductive characteristics - the size of the litter of the first and the other parities, as well as the percentage of sows that gave birth in relation to previous breeding process. Data of the 11637 tested gilts that completed the performance test have been used for the test. The studied characteristics were: the weight-gain at the end of the test, the number of live-born piglets, the number of stillborn piglets and the number of grown-weaned piglets in the first litter and the total number of live-born piglets, the total number of stillborn piglets and the total number of grown-weaned piglets. The results obtained in this study showed the effect of weight-gain in the reproductive efficacy test in the number of the live-born piglets in the first and from the 2nd to the 9th parity, as well as the percentage of the sows included in the next breeding process. By including all selected independent variables that showed the adequate statistical significance in correlation with the dependent variable, the determination coefficient rises to a value of 0.098 which represents 9.80% of the influence on the dependent variable, that can be explained by the independent variable, which leads to the conclusion that the binding strength between the variable "average live" and all the independent variables: "the number of litters", the MLD depth" and "the back-fat thickness", is very weak, which is not a rare case in multiple regression.(AU)


A eficácia reprodutiva das porcas dita o nível de rentabilidade da própria produção, e o momento do teste e seleção de leitoas para reprodução (como os pais de uma geração futura) representa um momento muito importante. Dado o fato de que a seleção de leitoas para criação é parcialmente baseada no ganho de peso no teste, neste estudo examinamos a influência de um ganho de peso diário de leitoas no teste da manifestação de importantes características reprodutivas - o tamanho da ninhada da primeira e das outras paridades, assim como a porcentagem de porcas que deram à luz em relação ao processo de criação anterior. Os dados das 11637 leitoas testadas que completaram o teste de desempenho foram utilizados para o teste. As características estudadas foram: o ganho de peso ao final do teste, o número de leitões nascidos vivos, o número de leitões natimortos e o número de leitões desmamados na primeira ninhada e o número total de leitões nascidos vivos , o número total de leitões natimortos e o número total de leitões desmamados. Os resultados obtidos neste estudo mostraram o efeito do ganho de peso no teste de eficácia reprodutiva no número de leitões nascidos vivos na primeira e da segunda à nona paridade, bem como a porcentagem de porcas incluídas na próximo processo de criação. Ao incluir todas as variáveis independentes selecionadas que mostraram a significância estatística adequada em correlação com a variável dependente, o coeficiente de determinação sobe para um valor de 0.098 que representa 9.80% da influência sobre a variável dependente, que pode ser explicada pela variável independente, que leva à conclusão de que a força de ligação entre a variável "média viva" e todas as variáveis independentes: "o número de ninhadas", a profundidade MLD "e" a espessura de gordura "é muito fraca, o que não é raro caso em regressão múltipla.(AU)


Asunto(s)
Animales , Femenino , Embarazo , Paridad , Porcinos/genética , Ganancia de Peso Gestacional , Tamaño de la Camada , Mortinato/veterinaria
2.
Int J Tuberc Lung Dis ; 17(11): 1495-500, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24125457

RESUMEN

BACKGROUND: Tuberculosis (TB) is associated with oxidative stress and is traditionally linked to vitamin C deficiency. OBJECTIVE: To evaluate the time course of the oxidative stress marker, malondialdehyde (MDA), and vitamin C status during the clinical treatment of tuberculous meningitis (TBM). METHOD: MDA and vitamin C reduction/oxidation (redox) status were spectrophotometrically measured at admission and during hospital treatment in cerebrospinal fluid (CSF) and serum from 27 TBM patients and 20 controls. RESULTS: Baseline CSF and serum MDA levels in TBM patients were higher than in controls (both P < 0.05), and remained elevated throughout the study. CSF MDA steadily increased from baseline 0.66 ± 0.24 mol/l to 1.02 ± 0.33 µmol/l at the end of the sixth week of treatment (P < 0.05), and then returned to baseline levels. Baseline CSF and serum total vitamin C were lower in TBM patients than in controls, but were soon normalised. CSF and serum ascorbate, reduced/oxidised vitamin C ratios and ascorbate CSF/serum ratio were markedly decreased in TBM patients (P < 0.05), and showed no improvement during treatment. CONCLUSION: These results indicate increased local and systemic oxidative stress, accompanied by impaired redox status, but not total vitamin C deficiency, which persisted during conventional clinical treatment of TBM.


Asunto(s)
Antituberculosos/uso terapéutico , Ácido Ascórbico/sangre , Ácido Ascórbico/líquido cefalorraquídeo , Estrés Oxidativo/efectos de los fármacos , Tuberculosis Meníngea/tratamiento farmacológico , Deficiencia de Ácido Ascórbico/sangre , Deficiencia de Ácido Ascórbico/líquido cefalorraquídeo , Biomarcadores/sangre , Biomarcadores/líquido cefalorraquídeo , Estudios de Casos y Controles , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Malondialdehído/sangre , Malondialdehído/líquido cefalorraquídeo , Oxidación-Reducción , Espectrofotometría , Factores de Tiempo , Resultado del Tratamiento , Tuberculosis Meníngea/sangre , Tuberculosis Meníngea/líquido cefalorraquídeo , Tuberculosis Meníngea/diagnóstico
3.
Biomed Pharmacother ; 67(6): 517-20, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23639229

RESUMEN

UNLABELLED: Despite the fact that the majority of prevalent and incident cases of HCV are associated with intravenous drug use (IVDU), these patients have largely been excluded from HCV care. The aim of this study was to examine the treatment outcome of chronic hepatitis C in IVDUs compared to non-IVDUs. PATIENTS AND METHODS: Patients with chronic hepatitis C (CHC) who initiated and completed combination antiviral therapy with pegilated interferon and ribavirin, at the Hepatology Department of the University Hospital for Infectious and Tropical Diseases in Belgrade, were retrospectively analyzed. The study included a series of 254 patients of which 100 (39.4%) were former IVDU. RESULTS: Sustained virological response (SVR) was recorded in a total of 172 patients (67.7%). The analyses of the favorable treatment outcome, regarding particular viral genotypes, revealed that among those with genotype 1 and/or 4, including patients with genotype 1 recombinants with genotype 3, SVR was achieved in 114 (63.3%), while it was almost equally distributed between subgroups of former IVDU and all others (P=0.079). Among patients infected with HCV genotypes 2 and/or 3 the SVR rate was as high as 86.6%. CONCLUSION: IVDU with CHC infection should be treated with standard combination antiviral therapy for CHC, since the success rate is equal or even better than in non-IVDU patients.


Asunto(s)
Antivirales/uso terapéutico , Hepatitis C Crónica/tratamiento farmacológico , Interferón-alfa/uso terapéutico , Polietilenglicoles/uso terapéutico , Ribavirina/uso terapéutico , Abuso de Sustancias por Vía Intravenosa/complicaciones , Abuso de Sustancias por Vía Intravenosa/virología , Adulto , Combinación de Medicamentos , Femenino , Hepacivirus/efectos de los fármacos , Hepatitis C Crónica/virología , Humanos , Masculino , ARN Viral/efectos de los fármacos , Proteínas Recombinantes/uso terapéutico , Estudios Retrospectivos , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...